Alpha-tropomysin (TPM1) Mutation Analysis
Sodium, Random, Urine
Metabolic Storage Disease Gene Mutation Panel, NGS
Fungal Culture, Body Fluid
Mitochondrial Fission Factor (MFF) Gene Mutation Analysis
Arylsulfatase A, 24 Hour, Urine
West Nile Virus (WNV) Antibody, IgG
HLA Class I and II typing, Antigen or Genotyping
CHIC2, 4q12 Deletion (FIP1L1 and PDGFRA Fusion), FISH, Blood
ESOPREDICT® Barrett's Esophagus Risk Classifier Assay
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test
Turnaround Time
Access to
Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
is restricted.
Sign up now